Cargando…
Integrative analysis reveals CD38 as a therapeutic target for plasma cell-rich pre-disease and established rheumatoid arthritis and systemic lupus erythematosus
BACKGROUND: Plasmablasts and plasma cells play a key role in many autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This study was undertaken to evaluate the potential of targeting CD38 as a plasma cell/plasmablast depletion mechanism by daratumumab in th...
Autores principales: | Cole, Suzanne, Walsh, Alice, Yin, Xuefeng, Wechalekar, Mihir D., Smith, Malcolm D., Proudman, Susanna M., Veale, Douglas J., Fearon, Ursula, Pitzalis, Costantino, Humby, Frances, Bombardieri, Michele, Axel, Amy, Adams, Homer, Chiu, Christopher, Sharp, Michael, Alvarez, John, Anderson, Ian, Madakamutil, Loui, Nagpal, Sunil, Guo, Yanxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932888/ https://www.ncbi.nlm.nih.gov/pubmed/29720240 http://dx.doi.org/10.1186/s13075-018-1578-z |
Ejemplares similares
-
Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression
por: Guo, Yanxia, et al.
Publicado: (2018) -
Triple DMARD treatment in early rheumatoid arthritis modulates synovial T cell activation and plasmablast/plasma cell differentiation pathways
por: Walsh, Alice M., et al.
Publicado: (2017) -
Editorial: Synovial pathobiology and pathogenesis of inflammatory arthritis
por: Small, Annabelle, et al.
Publicado: (2022) -
Transcriptomic profiling of programmed cell death 1 (PD-1) expressing T cells in early rheumatoid arthritis identifies a decreased CD4 + PD-1 + signature post-treatment
por: Lowe, Katie, et al.
Publicado: (2023) -
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
por: Humby, Frances, et al.
Publicado: (2009)